Among the 39 patients with AFP-negative HCC at diagnosis (< 20 ng/mL), 51.2% patients had hPG80 > 7.73 pM, meaning that hPG80 could potentially compensate the false-negative AFP. This evidence concerns the gene AFP and hepatocellular carcinoma.